To compensate for MEDI3622-inhibited VEGF shedding during the transwell migration assay, exogenous VEGF was added to the secretome, which could fully reactivate HUVEC migration toward irradiated tumor cells (Fig. 2D). The gene discussed is VEGFA; the disease is neoplasm.